TSC participated in the 22nd National Innovation Award's
"Enterprise Innovation Award - Agricultural and Food Biotechnology
Category" with its "Next-generation Porcine Epidemic Diarrhea (PED)
vaccine enhancing lactogenic immunity". After a three-stage review by the
judging panel, it successfully stood out for its technological breakthrough,
application benefits, and industrial value, winning the annual National
Innovation Award. The award ceremony was held in Grand Hilai Taipei, and was
personally presented by Prime Minister Jung-Tai Cho. TSC Chairman Ming-Chang Wu
led the research team of the project, including Taiwan Sugar Research Institute
(TSRI) Director, I-Jen Huang, Section Leader, Ji-Ming Yang, and Dr. Dai-Ji Li,
to attend the ceremony, demonstrating TSC's deep commitment to developing
independent animal vaccine technologies.
The National Innovation Award is a benchmark competition
in the domestic medical and biotechnology fields. TSRI won the award for its
independently developed PED vaccine with lactation immunity, demonstrating the
innovative value of this vaccine technology in both scientific merit and
practical application. It also reflects the achievements of TSC in recent years
in actively promoting sustainable livestock, biotechnology R&D, and
industrial upgrading. This national-level award is expected to strengthen industry
chain connections, increase technological visibility, and promote
commercialization.
TSC Chairman Ming-Chang Wu emphasized that
"promoting biotechnology autonomy and protecting the local livestock
industry are long-term goals of Taiwan Sugar Corporation". He added that
TSC will continue to deepen its vaccine platform and application research to
help the industry reduce disease risks, improve overall survival rates, and
increase production efficiency. Director of TSRI, Dr. I-Jen Huang, stated that
this award not only represents the innovative breakthroughs of the Taiwan Sugar
Research Institute in animal vaccine technology but also symbolizes a
significant milestone for TSC in biotechnology investment, industry-academia
collaboration, and sustainable livestock strategies.
TSC stated that it hopes to leverage this National
Innovation Award recognition to accelerate the commercialization of vaccines
and align them with international standards. It will also continue to build a
more comprehensive animal vaccine technology framework to provide safer,
standardized, and sustainable disease prevention solutions for the pig farming
industry in Taiwan and globally.
